This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MetLife (MET) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
MetLife's (MET) fourth-quarter results are likely to reflect lower interest rates and higher COVID-19 related claims, partly offset by strong underwriting margins.
Hartford Financial (HIG) Launches Plan for Mental Health
by Zacks Equity Research
Hartford Financial (HIG) introduces a plan to ease the financial stress of people suffering mental health illnesses.
The Zacks Analyst Blog Highlights: Novartis, QUALCOMM, Accenture, MetLife and Electronic Arts
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Novartis, QUALCOMM, Accenture, MetLife and Electronic Arts
Top Stock Reports for Novartis, QUALCOMM & Accenture
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novartis (NVS), QUALCOMM (QCOM), and Accenture (ACN).
Aflac (AFL) Grows Product Menu Via New Dental & Vision Offers
by Zacks Equity Research
Aflac (AFL) introduces a dental and vision insurance package, thereby widening its product portfolio in the U.S. segment.
MetLife (MET) Unit to Reinsure Legal & General's Longevity Risk
by Zacks Equity Research
MetLife's (MET) subsidiary inscribes four agreements in a bid to foray deeper into the U.K. longevity risk transfer market.
Here's Why Hartford Financial (HIG) Stock is an Attractive Bet Now
by Zacks Equity Research
Hartford Financial (HIG) remains well-poised for growth on the back of impressive performance in Commercial Lines business and sound capital position.
AIG Declines 27% Year to Date: Will It Recover in 2021?
by Zacks Equity Research
AIG has undertaken a host of initiatives including dispositions, which raises hopes for the next year following a dismal period of COVID-19 induced business loss.
Hartford Financial (HIG) Unveils Share Buyback Program Worth $1.5B
by Zacks Equity Research
Hartford Financial's (HIG) board raises share buyback authorization, which showcases its sound financial standing and constant efforts to support prudent capital deployment.
Aflac (AFL) Down 13% in 2020: Will It Bounce Back in 2021?
by Zacks Equity Research
A slew of initiatives recently taken by Aflac (AFL) should aid the stock in 2021 after suffering from COVID-led business loss in 2020.
MetLife (MET) Dips 5% Year to Date: Will it Recover in 2021?
by Zacks Equity Research
Strategic initiatives, such as acquisitions and dispositions, strong business and a gradually improving economic environment will drive MetLife's (MET) shares in 2021.
MetLife (MET) Announces Share Buyback Program Worth $3B
by Zacks Equity Research
MetLife's (MET) board raises share buyback authorization, which reflects its strong financial position and constant efforts to support prudent capital deployment.
MetLife (MET) to Sell Auto & Home Units to Streamline Business
by Zacks Equity Research
MetLife (MET) is working toward shedding the home and auto business from its portfolio and penetrating the domain of life and health insurance and other benefits offerings.
Why Is MetLife (MET) Up 16% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MetLife's (MET) Business Restructuring on Track for Efficiency
by Zacks Equity Research
MetLife (MET) is reportedly considering the sale of its property and casualty business to focus on more profitable areas.
AIG's Q3 Earnings Beat Estimates & Grow Y/Y, Revenues Miss
by Zacks Equity Research
AIG's third-quarter results reflect premium rate increases across the commercial lines business and reduced costs, partly offset by lower revenues.
Brighthouse (BHF) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Brighthouse Financial's (BHF) third-quarter results reflect growth in annuity and life sales, partly offset by higher expenses.
Allstate's (ALL) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Allstate's (ALL) Q3 earnings reflect an increase in premiums and higher expenses due to restructuring charges.
MetLife (MET) Earnings and Revenues Beat Estimates in Q3
by Zacks Equity Research
MetLife's (MET) third-quarter results reflect sound underwriting results and reduced costs, partly offset by muted revenues.
MetLife (MET) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 4.85% and 3.69%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stock Q3 Earnings Due on Nov 4: MET, ALL & More
by Zacks Equity Research
Third-quarter results of ALL, MET, LNC, SLF and FNF are likely to reflect improved pricing, strong retention and stable new businesses, partially offset by cat losses and a lower interest rate.
What's in Store for MetLife's (MET) This Earnings Season?
by Zacks Equity Research
Most segments of MetLife (MET) in Q3 are likely to have fared poorly with a drop in adjusted premiums, fees and other revenues. Low interest rates might have dragged down investment income.
6 Multiline Insurers to Watch Out for Amid Operational Challenges
by Tanuka De
Better pricing, product redesigns and increased adoption of technology are expected to aid multiline insurers like CI, MET, CNO, HMN, ORI, and MTG. However, a low-rate environment remains a headwind.
MetLife (MET) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy MetLife (MET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.